Epigallocatechin Gallate (EGCG) as a Flushing Agent During Full Pulpotomy in Mature Permanent Molars With Irreversible Pulpitis
The Influence of Epigallocatechin Gallate (EGCG) as a Flushing Agent During Full Pulpotomy Using Two Different Calcium Silicate-based Materials on Postoperative Pain and Success Rate in Mature Permanent Molars With Irreversible Pulpitis: A Randomized Clinical Trial
1 other identifier
interventional
64
1 country
1
Brief Summary
This study evaluates the effect of two flushing agents (epigallocatechin gallate (EGCG) and sodium hypochlorite (NaOCl)) during full pulpotomy using two different calcium silicate-based materials (MTA and premixed bioceramic putty) on postoperative pain, success rate and dentin bridge thickness in mature permanent mandibular molars with irreversible pulpitis. Participants will be divided into four groups based on the flushing fluid and the pulp capping material to be used.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 18, 2023
CompletedFirst Posted
Study publicly available on registry
April 13, 2023
CompletedStudy Start
First participant enrolled
July 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
ExpectedMarch 25, 2026
March 1, 2026
2 years
March 18, 2023
March 22, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Postoperative pain
Pain assessments will be made at 24, 48, 72 hours postoperatively using an 11-point NRS. Pain will be categorized into 4 categories as follows: 0 reading represents "no pain"; 1- 3 readings represent "mild pain"; 4- 6 readings represent "moderate pain"; 7- 10 readings represent "severe pain".
72 hours
Secondary Outcomes (3)
Clinical success
One year follow-up
Radiographic success
One year follow-up
Dentin bridge formation
12 months follow-up
Study Arms (4)
EGCG as a flushing fluid, MTA as a pulp capping material
EXPERIMENTALEGCG as a flushing fluid, Premixed BC putty as a pulp capping material
EXPERIMENTALNaOCl as a flushing fluid, Premixed BC putty as a pulp capping material
EXPERIMENTALNaOCl as a flushing fluid, MTA as a pulp capping material
ACTIVE COMPARATORInterventions
Mineral trioxide aggregate (MTA) is the material of choice for pulp capping in vital pulp therapy.
Epigallocatechin gallate (EGCG) is a white powder that can be obtained from tea leaves. It accounts for 50-60 % of catechin content of tea polyphenols with a wide range of biological activities including antioxidant, antimicrobial, anti-inflammatory, immune regulatory, anti-tumour effects.
Sodium hypochlorite (NaOCl) is an excellent non-specific proteolytic and antimicrobial agent that provides disinfection of the dentin-pulp interface.
Bioceramic putty is a premixed, ready-to-use calcium silicate-based material which can be used as a pulp capping material.
Eligibility Criteria
You may qualify if:
- Patients of either gender between the age group of 20-40 years.
- Systemically healthy patient (ASA I or II).
- Mature permanent mandibular molars with:
- Extremely deep carious lesion (caries penetrating entire thickness of dentin).
- Clinical diagnosis of symptomatic irreversible pulpitis and normal periapical tissue.
- Patients who agree to provide written consent and attend for recall appointments.
You may not qualify if:
- Non-restorable teeth with subgingival caries or badly broken teeth.
- Signs of pulpal necrosis; associated sinus tract or swelling.
- Negative response to pulp sensibility test.
- Poor periodontal support.
- Absence of pulp exposure following complete caries removal.
- Bleeding from the pulp could not be detected from one or more of the orifices indicating pulp necrosis.
- Failure to achieve haemostasis within 10 min following full pulpotomy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Faculty of Dentistry, Cairo University
Cairo, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- The investigator will not be blinded because of the nature of the intervention and comparator (the flushing agent and pulp capping material)
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant lecturer, Ahram Canadian university
Study Record Dates
First Submitted
March 18, 2023
First Posted
April 13, 2023
Study Start
July 1, 2023
Primary Completion
June 30, 2025
Study Completion (Estimated)
June 30, 2026
Last Updated
March 25, 2026
Record last verified: 2026-03